Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008 Nov;88(5):1438-46. doi: 10.3945/ajcn.2008.26242. linkinghub.elsevier.com/retrieve/pii/S0002-9165(23)23376-6
Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508–518. doi: 10.1111/j.1365-2036.2008.03911.x. https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.2008.03911.x
Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur J Clin Nutr. 2010 Feb;64(2):146-52. doi: 10.1038/ejcn.2009.120 https://www.nature.com/articles/ejcn2009124.pdf
Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013;143(3):324–331. doi: 10.3945/jn.112.166132. https://www.sciencedirect.com/science/article/pii/S0022316622011324?via%3Dihub
Mego M, Manichanh C, Accarino A, Campos D, Pozuelo M, Varela E, Vulevic J, Tzortzis G, Gibson G, Guarner F, Azpiroz F. Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study. Aliment Pharmacol Ther. 2017 Mar;45(5):670-680. doi: 10.1111/apt.13931. https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.13931
Hasle G, Raastad R, Bjune G, Jenum PA, Heier L. Can a galacto-oligosaccharide reduce the risk of traveller’s diarrhoea? A placebo-controlled, randomized, double-blind study. J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax057. https://academic.oup.com/jtm/article-abstract/24/5/tax057/4085921
Kao AC, Safarikova J, Marquardt T, Mullins B, Lennox BR, Burnet PWJ. Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study. Schizophr Res. 2019 Jun;208:460-461. doi: 10.1016/j.schres.2019.03.003. linkinghub.elsevier.com/retrieve/pii/S0920-9964(19)30085-4
Capitão LP, Baião R, Baek HK, Kappelmann N, Sharman R, Harvey CJ, Montgomery P, Burnet PW. Prebiotic supplementation does not affect reading and cognitive performance in children: A randomised placebo-controlled study. J Psychopharmacol. 2020 Jan;34(1):148-152. doi: 10.1177/0269881119862534. https://journals.sagepub.com/doi/10.1177/0269881119862534
Parker C, Hunter KA, Johnson MA, Sharpe GR, Gibson GR, Walton GE, Poveda C, Cousins B, Williams NC. Effects of 24-week prebiotic intervention on self-reported upper respiratory symptoms, gastrointestinal symptoms, and markers of immunity in elite rugby union players. Eur J Sport Sci. 2023 Nov;23(11):2232-2239. doi: 10.1080/17461391.2023.2216657. https://onlinelibrary.wiley.com/doi/10.1080/17461391.2023.2216657